{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-10-31T12:23:54.165696+00:00",
  "news": [
    {
      "title": "Strs Ohio Purchases 12,292 Shares of Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNUnFhaU9tZC1VRGNsamx6SllBZno0QWtseWREek9qc2k1YkE3WVBTUGhTUWdoZWJfeTFiOU0wR0tscWNCU29xeVVEMWFacl92N0lHbmw2bW1Bbk9oVHVwbnlJZFIwQnowdl9WUHQyZDFBUjZhWE9rcTlYQV9vLXFFSlN6c0doT0l6SUFmZUlhN0VvMG9oZGpDLTZVanFXYm45V3lCR01CYmZvNm03WDBxMA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxNUnFhaU9tZC1VRGNsamx6SllBZno0QWtseWREek9qc2k1YkE3WVBTUGhTUWdoZWJfeTFiOU0wR0tscWNCU29xeVVEMWFacl92N0lHbmw2bW1Bbk9oVHVwbnlJZFIwQnowdl9WUHQyZDFBUjZhWE9rcTlYQV9vLXFFSlN6c0doT0l6SUFmZUlhN0VvMG9oZGpDLTZVanFXYm45V3lCR01CYmZvNm03WDBxMA?oc=5\" target=\"_blank\">Strs Ohio Purchases 12,292 Shares of Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-10-31T12:19:46+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Amgen Sues Colorado Again as State Adopts Payment Cap on Enbrel - Bloomberg Law News",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNekV4T0l2ZXZCN2ZpeHhWTjREVmtVSTU1SEZhd2h5ankxTnJMR3hZU0NmcXlLazVIVFYzT2VpVkFia0NWVFVjZno3bnFtSkVnVFlNc013Nm5nM1B4M1V6cE00QTB3cTRweWtmWEw5UFk3ZlNPeHhheEw2cHUzdFJIS2VUSC1nank3UDJsSklkM3NZZ2dsOG5aZWtjcTMxSnV3MzY5NTJYSDY0MXBrMXJrRTJ3Snk3OTlH?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNekV4T0l2ZXZCN2ZpeHhWTjREVmtVSTU1SEZhd2h5ankxTnJMR3hZU0NmcXlLazVIVFYzT2VpVkFia0NWVFVjZno3bnFtSkVnVFlNc013Nm5nM1B4M1V6cE00QTB3cTRweWtmWEw5UFk3ZlNPeHhheEw2cHUzdFJIS2VUSC1nank3UDJsSklkM3NZZ2dsOG5aZWtjcTMxSnV3MzY5NTJYSDY0MXBrMXJrRTJ3Snk3OTlH?oc=5\" target=\"_blank\">Amgen Sues Colorado Again as State Adopts Payment Cap on Enbrel</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Bloomberg Law News</font>",
      "published": "2025-10-30T20:39:00+00:00",
      "source": "Bloomberg Law News"
    },
    {
      "title": "AMGEN ANNOUNCES WEBCAST OF 2025 THIRD QUARTER FINANCIAL RESULTS - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxORjI4R1dfNjFFTXVtSU96NTZkd0hpRmtfMllLU3Z2U1hzRmZDZEwwaUs4WF9lR2c1VjZuaGg3MC10amVDWkU0Sl8wQ0ZZRjFXWm04SlBTMm5wV2VjNmJYV2VuMmNSSXhLUk9YcG1LUjBqUDZIOHhYWnVaR2ptQXZ1NG1VSmp6OVE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxORjI4R1dfNjFFTXVtSU96NTZkd0hpRmtfMllLU3Z2U1hzRmZDZEwwaUs4WF9lR2c1VjZuaGg3MC10amVDWkU0Sl8wQ0ZZRjFXWm04SlBTMm5wV2VjNmJYV2VuMmNSSXhLUk9YcG1LUjBqUDZIOHhYWnVaR2ptQXZ1NG1VSmp6OVE?oc=5\" target=\"_blank\">AMGEN ANNOUNCES WEBCAST OF 2025 THIRD QUARTER FINANCIAL RESULTS</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-29T20:01:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "US FDA expands use of Amgen, AstraZeneca's drug for chronic inflammatory sinus disease - Reuters",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPdHIxQV8zM2pKOENLQm1ULVdWcXd6b2wzYzhxd3p2aHE5ZTd5RWs0UWx6QTd1VDJ1RXpkbUVUWG1JT3UzSmZrVER6OUVMNFNSZXFGa2FWdmpaVWxsVVl3VFNhS1hydC1YaDgwTDdob3l1dFBFaU9PZTVwUXpsM3AteGZ2ZjhFd2FJYWlfbzFWcUxacFFPOU9rQUNNWXprUUZmTTQwRHpzcjRRZTV0ZEQ3QWdRMkpYNW9GUDlwcnY4d3ROTEE0bS1tZldB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxPdHIxQV8zM2pKOENLQm1ULVdWcXd6b2wzYzhxd3p2aHE5ZTd5RWs0UWx6QTd1VDJ1RXpkbUVUWG1JT3UzSmZrVER6OUVMNFNSZXFGa2FWdmpaVWxsVVl3VFNhS1hydC1YaDgwTDdob3l1dFBFaU9PZTVwUXpsM3AteGZ2ZjhFd2FJYWlfbzFWcUxacFFPOU9rQUNNWXprUUZmTTQwRHpzcjRRZTV0ZEQ3QWdRMkpYNW9GUDlwcnY4d3ROTEE0bS1tZldB?oc=5\" target=\"_blank\">US FDA expands use of Amgen, AstraZeneca's drug for chronic inflammatory sinus disease</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-10-17T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "With questions surrounding its gastric cancer drug, Amgen fills in some gaps - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMie0FVX3lxTE1zNDBYYlJHWGU3TktJb1dpeUI0MkUxZFBpQklTbW1YT3BWWGw4RjVNSm5BOFBZTUJDamRmNUg3bVJaOHhqV21QZXF0MzdBOU14V1JVZVhseWNaSTI4M2NGa0xkbUJLVHhvel9SWDhYd251Y3l3aFAzZkZndw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMie0FVX3lxTE1zNDBYYlJHWGU3TktJb1dpeUI0MkUxZFBpQklTbW1YT3BWWGw4RjVNSm5BOFBZTUJDamRmNUg3bVJaOHhqV21QZXF0MzdBOU14V1JVZVhseWNaSTI4M2NGa0xkbUJLVHhvel9SWDhYd251Y3l3aFAzZkZndw?oc=5\" target=\"_blank\">With questions surrounding its gastric cancer drug, Amgen fills in some gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2025-10-20T07:00:00+00:00",
      "source": "statnews.com"
    },
    {
      "title": "Evaluating Amgen (AMGN): Is Current Valuation Attractive After Recent 1-Month Momentum? - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Evaluating Amgen (AMGN): Is Current Valuation Attractive After Recent 1-Month Momentum?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-10-30T05:39:26+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices - The New York Times",
      "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPOGtMT0RzU0RhVGtHcjRGc1ZveDNZOUJLMGh3eVB2S3Eyb21tSUpmczRHUEtmWUYtdnlXVGNFUHN6RUVNa3BtZGNGcG1zVEJaZEZUdi03R2R4VHVENzBxcjhrektwRTNFOWpOSTZuSzFpbkRWZktQeDROQkdiV0RCcnBpRFljTDRXSkhWbklkZFhNLW8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxPOGtMT0RzU0RhVGtHcjRGc1ZveDNZOUJLMGh3eVB2S3Eyb21tSUpmczRHUEtmWUYtdnlXVGNFUHN6RUVNa3BtZGNGcG1zVEJaZEZUdi03R2R4VHVENzBxcjhrektwRTNFOWpOSTZuSzFpbkRWZktQeDROQkdiV0RCcnBpRFljTDRXSkhWbklkZFhNLW8?oc=5\" target=\"_blank\">Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The New York Times</font>",
      "published": "2025-10-23T09:00:45+00:00",
      "source": "The New York Times"
    },
    {
      "title": "AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxOVC03UXRKQ3Q4OTFzYjh5bUV6WWRRRHVOU2pqcDY1MGhUbm1PQnZCTEpQYzZhcFlsN2pDSHZTU0xib0JuVVhuTlBMMVVuRGhtX1F0clBxVHM2Z2lUR1VRSkItM3VvVGh6R0NPMWhaTkRZRGVOVlFhNzdGUkZ5UWpzRk4zU2xIdkdRMkFrRl83UjB2LXFjMWdRUXh1aUs3WG94SXI5NWJqVVEyYzFSZVY5TERfZGlJOC1DbVM4RnNBbFJOVW9GbW9PQ1NydXBsdHdtTkE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOVC03UXRKQ3Q4OTFzYjh5bUV6WWRRRHVOU2pqcDY1MGhUbm1PQnZCTEpQYzZhcFlsN2pDSHZTU0xib0JuVVhuTlBMMVVuRGhtX1F0clBxVHM2Z2lUR1VRSkItM3VvVGh6R0NPMWhaTkRZRGVOVlFhNzdGUkZ5UWpzRk4zU2xIdkdRMkFrRl83UjB2LXFjMWdRUXh1aUs3WG94SXI5NWJqVVEyYzFSZVY5TERfZGlJOC1DbVM4RnNBbFJOVW9GbW9PQ1NydXBsdHdtTkE?oc=5\" target=\"_blank\">AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-09-26T07:00:00+00:00",
      "source": "PR Newswire"
    }
  ],
  "product_launches": [
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "$239/month for Repatha — AmgenNow direct-to-patient program offers nearly 60% discount in U.S. - Stock Titan",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNX1VmYlB3RmtYTG5rd1dJblFhNVh6UEFHdzkxTm9VRy0wMVc1SDNuZ0JLYUNRTHA0VVhBOEpWb1RUa2FONTVMY19CSTJSVVJSUjFwbkIwMFdtalFEWHRmQTVvQnFzY3YxYUFqaDc2cjBydnV0RjdSWGhCTzdaWDl1Y2VNVU9LdzZvLW1FZHhnam12Qm1XaEg0M3ZEeTh4aHNkcUZsazNRa0tuTGY3WXNiZjZKSnh2SkJRVVl6OXRR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxNX1VmYlB3RmtYTG5rd1dJblFhNVh6UEFHdzkxTm9VRy0wMVc1SDNuZ0JLYUNRTHA0VVhBOEpWb1RUa2FONTVMY19CSTJSVVJSUjFwbkIwMFdtalFEWHRmQTVvQnFzY3YxYUFqaDc2cjBydnV0RjdSWGhCTzdaWDl1Y2VNVU9LdzZvLW1FZHhnam12Qm1XaEg0M3ZEeTh4aHNkcUZsazNRa0tuTGY3WXNiZjZKSnh2SkJRVVl6OXRR?oc=5\" target=\"_blank\">$239/month for Repatha — AmgenNow direct-to-patient program offers nearly 60% discount in U.S.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stock Titan</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "Stock Titan"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-10-30",
      "close": 292.0
    },
    "history": [
      {
        "date": "2025-10-22",
        "close": 295.9800109863281
      },
      {
        "date": "2025-10-23",
        "close": 292.8900146484375
      },
      {
        "date": "2025-10-24",
        "close": 291.760009765625
      },
      {
        "date": "2025-10-27",
        "close": 291.1600036621094
      },
      {
        "date": "2025-10-28",
        "close": 292.0899963378906
      },
      {
        "date": "2025-10-29",
        "close": 291.7699890136719
      },
      {
        "date": "2025-10-30",
        "close": 292.0
      }
    ],
    "name": "Amgen Inc."
  }
}